PAR paradigm biopharmaceuticals limited..

research reports and media, page-1274

  1. 49 Posts.
    lightbulb Created with Sketch. 9
    Once the GP clinics start to realise the true potential of PPS through TGA announcements/ our drug reps and also potentially change in prescribing and treatment guidelines for OA as a whole, this will totally rerate. I'd suspect once the typical NSAID's and Panadol Osteo have been exhausted, PPS will be first choice. The recent trends of Prolia injections for Osteoporosis and medicinal cannabis have been huge, I've seen this first hand working at a GP clinic and this has been great for the patients overall outcomes as far as I have seen. I could mention the Opioid Treatment Programs and how the trend of opioid prescribing is looking at tightening restrictions on opioid prescribing to reverse the potential of addiction . Although far different fields, I can see that once GP's push for use of it, you will see most clinics stocking right up with a steady flow of patients waiting, and that will reflect on the SP. Whether it has our logo on it or not, that remains unknown. Hold tight everyone, so far I've managed to convince 1 GP to jump onboard but I'll keep spreading the good message. Just my thoughts.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.020(5.00%)
Mkt cap ! $166.9M
Open High Low Value Volume
40.0¢ 42.5¢ 39.5¢ $239.2K 576.9K

Buyers (Bids)

No. Vol. Price($)
3 8734 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 52500 3
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.